title: Effects of inhalation and intravenous anesthetic agents on pressor response to NG-nitro-L-arginine.
abstract: The effects of anaesthetic agents on pressor effect of NG-nitro-L-arginine (L-NNA), a potent inhibitor of nitric oxide (NO) synthesis, were examined in rats. I.v. bolus of L-NNA (1-32 mg/kg) in conscious rats dose dependently increased mean arterial pressure (MAP) to a maximum value of 53 +/- 2 mmHg at 16 mg/kg with ED50 value of 4.7 +/- 0.9 mg/kg. The effects of a single i.v. bolus dose (32 mg/kg) of L-NNA were examined in conscious rats and rats anaesthetised with pentobarbital, chloralose, ketamine, althesin (mixture of alphaxalone and alphadolone), urethane, enflurane or halothane. In conscious rats, peak MAP (51 +/- 3 mmHg) was reached 10 min after i.v. injection and the effect lasted more than two hours. The magnitudes of peak MAP differed under the influence of anaesthetic agents with the following rank order: althesin greater than conscious = pentobarbital = chloralose = ketamine = urethane greater than enflurane much greater than halothane (in which there was negligible change in MAP). The onsets were delayed in rats anaesthetised with pentobarbital, althesin, chloralose and enflurane but not altered with ketamine and urethane compared to that in conscious rats. Therefore, L-NNA caused intense and prolonged pressor response in conscious rats and rats anaesthetised with the i.v. anaesthetic agents pentobarbital, chloralose, ketamine, althesin and urethane. MAP effect of L-NNA was markedly attenuated by the inhalation anaesthetics halothane and enflurane.
authors.affiliation: Department of Pharmacology and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
authors.forename: Y X
authors.initials: YX
authors.lastname: Wang
authors.forename: T
authors.initials: T
authors.lastname: Zhou
authors.forename: T C
authors.initials: TC
authors.lastname: Chua
authors.forename: C C
authors.initials: CC
authors.lastname: Pang
mesh_terms: D000530:Alfaxalone Alfadolone Mixture / Q000008:administration & dosage / Q000494:pharmacology; D000769:Anesthesia, Inhalation; D000771:Anesthesia, Intravenous; D000777:Anesthetics / Q000494:pharmacology*; D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects* / Q000502:physiology; D002698:Chloralose / Q000008:administration & dosage / Q000494:pharmacology; D004737:Enflurane / Q000008:administration & dosage / Q000494:pharmacology; D006221:Halothane / Q000008:administration & dosage / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects*; D007649:Ketamine / Q000008:administration & dosage / Q000494:pharmacology; D019335:Nitroarginine; D010424:Pentobarbital / Q000008:administration & dosage / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D014520:Urethane / Q000008:administration & dosage / Q000494:pharmacology
chemical_list: D000777:Anesthetics; D019335:Nitroarginine; D002698:Chloralose; D014520:Urethane; D007649:Ketamine; D000530:Alfaxalone Alfadolone Mixture; D004737:Enflurane; D001120:Arginine; D010424:Pentobarbital; D006221:Halothane